-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ptc Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Ptc Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$54.5M, a 53.9% increase year-over-year.
- Ptc Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$134M, a 79.2% increase year-over-year.
- Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$440M, a 1.77% increase from 2022.
- Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$447M, a 19.5% decline from 2021.
- Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$374M, a 13.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)